# PEMAZYRE
> **NDA213736** · New Drug Application · Sponsor: INCYTE CORP · Approved 2020-04-17
## Drug
- **FDA Application Number:** NDA213736
- **Application type:** New Drug Application
- **Brand name:** PEMAZYRE
- **Generic name:** PEMIGATINIB
- **Active ingredients:** PEMIGATINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INCYTE CORP
- **Manufacturer:** Incyte Corporation
- **First approval:** 2020-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213736)
---
*AI Analytics · CC0 1.0*